NCT Number: NCT00812136
Parent Mentor Asthma Study
Asthma disproportionately affects minorities, but few studies have evaluated interventions to improve asthma outcomes in minority children.The purpose of the study is to determine whether Parent Mentors (PMs) are more effective than traditional asthma care in reducing minority children's asthma morbidity, costs, and use of services, while increasing families' quality of life and parental self-efficacy.
Looking for future studies?
Notify MeKey information
Conditions
Age range
2 year–18 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- The child was 2-18 years old
- African-American or Latino race/ethnicity for the child (by parental identification)
- Primary residence in a Milwaukee zip code
- ED or inpatient ward admission with a primary diagnosis of asthma.
Exclusion criteria
- Significant co-morbidity, including other pulmonary conditions, cardiac pathology, renal abnormalities, diabetes mellitus, epilepsy, and other co-morbidities that might lead to ED visits or hospitalizations, and current enrollment in a case management, intervention, or outreach program for childhood asthma management.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
University of Texas Southwestern Medical Center
Other
Registry information
Official study title
Using Parent Mentors to Improve Asthma Care for Urban Minority Children
Acronym: PMA
Important dates
- First posted
- Dec 22, 2008
- Registry last updated
- Apr 23, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Bioequivalence Study of Budesonide/Formoterol Inhalation Powder in Healthy Participants
NCT07804303
Asthma, Bronchial Diseases
Nanjing, Jiangsu, China
View Trial DetailsInhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)
NCT01721291
Asthma, Bronchial Diseases
London, United Kingdom
View Trial DetailsEvaluate Pharmacokinetics and Safety of Slow Release DHEA
NCT05623059
Asthma, Bronchial Diseases
Indianapolis, Indiana, United States
View Trial DetailsAgricultural Health Study Follow-up
NCT01399411
Asthma, Autoimmune Diseases
Iowa City, Illinois, United States
View Trial Details